Drug Shortage Report for TELMISARTAN
Report ID | 211180 |
Drug Identification Number | 02390345 |
Brand name | TELMISARTAN |
Common or Proper name | Telmisartan |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-08-14 |
Estimated end date | 2024-04-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-11-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-11-22 | French | Compare |
v1 | 2023-11-22 | English | Compare |
Showing 1 to 2 of 2